Explore patent oppositions filed by Glenmark Life Sciences against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 24, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Amorphous Lercanidipine HydrochlorideRECORDATI INDUSTRIA CHIMICA E FARMACEUTICANov 13, 2019

Explore Glenmark Life Sciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 22, 2025Process For Preparation Of Apremilast1